| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers (NCT04738786) | Samsung Medical Center | 2021-01-18 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Oral Stent Device for Radiation Treatments of Oral Cancers (NCT04041141) | Indiana University | 2019-09-25 |
| Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin (NCT04059861) | Region Örebro County | 2019-05-28 |
| Radiotherapy of Tongue Cancer Using an Intraoral Stent (NCT04337853) | Oslo University Hospital | 2018-03-09 |
| Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy (NCT04126226) | Hospital de Clinicas de Porto Alegre | 2018-03-01 |
| Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (NCT03181035) | Sunnybrook Health Sciences Centre | 2018-01-25 |
| Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue (NCT02584270) | University of Michigan | 2018-01-02 |
| High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer (NCT03008330) | Fuda Cancer Hospital, Guangzhou | 2016-12-01 |
| Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (NCT02295540) | Rutgers, The State University of New Jersey | 2016-08-01 |
| Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer (NCT02177838) | Rutgers, The State University of New Jersey | 2015-03-25 |
| Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer (NCT02245100) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-07-22 |
| Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (NCT02123511) | Mayo Clinic | 2014-04-01 |
| Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer (NCT01953952) | Radiation Therapy Oncology Group | 2013-12-01 |
| Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer (NCT01718223) | Roswell Park Cancer Institute | 2013-12-01 |
| Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer (NCT01949740) | University of Chicago | 2013-06-01 |
| Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer (NCT01854021) | tiejun Zhang | 2013-05-01 |
| Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy (NCT01674374) | Roswell Park Cancer Institute | 2013-05-01 |
| PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT01816984) | University of Chicago | 2013-05-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer (NCT01847326) | University of Chicago | 2013-03-26 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer (NCT01528137) | Stanford University | 2012-05-01 |
| A Study of Tongue Conservation Surgery for Oral Tongue Cancer (NCT03161548) | Taipei Veterans General Hospital, Taiwan | 2011-07-18 |
| TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck (NCT01334177) | University of Washington | 2011-06-01 |
| Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy (NCT01332279) | Fox Chase Cancer Center | 2011-04-01 |
| Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer (NCT01316757) | Fox Chase Cancer Center | 2011-02-16 |
| Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab (NCT00939627) | National Cancer Institute (NCI) | 2009-07-01 |
| Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care (NCT01816841) | Ohio State University Comprehensive Cancer Center | 2008-11-11 |
| Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer (NCT01637194) | Fox Chase Cancer Center | 2008-11-01 |
| Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT00906360) | National Cancer Institute (NCI) | 2008-07-01 |
| Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck (NCT01473784) | Ohio State University Comprehensive Cancer Center | 2007-12-03 |
| Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. (NCT01469429) | Ohio State University Comprehensive Cancer Center | 2007-09-04 |
| Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00507767) | National Cancer Institute (NCI) | 2007-07-01 |
| Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00513435) | National Cancer Institute (NCI) | 2007-07-01 |
| Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors (NCT01504932) | Ohio State University Comprehensive Cancer Center | 2007-02-23 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT00103259) | National Cancer Institute (NCI) | 2005-07-01 |
| GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer (NCT00293462) | Marilyn Dodd | 2005-06-07 |
| S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00096512) | National Cancer Institute (NCI) | 2004-10-01 |
| Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497) | National Cancer Institute (NCI) | 2003-08-01 |
| Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx (NCT00064103) | National Cancer Institute (NCI) | 2003-06-01 |
| Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck (NCT00033618) | National Cancer Institute (NCI) | 2002-11-01 |
| Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia (NCT00330382) | National Cancer Institute (NCI) | 1999-01-01 |